Par Drugs And Chemicals Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 28 October 2026

A price band is a fixed ceiling and floor around a reference price, and on 28 October 2026 Par Drugs And Chemicals Ltd. (PAR) pushed all the way to the top of it on NSE. The stock was held at Rs 114.96, up 5% from the previous close of Rs 109.49, which extends the Par Drugs And Chemicals upper circuit streak to 2 sessions.

Market cap stood at Rs 134.72 crore at the time of writing.

Key Takeaways

• Par Drugs And Chemicals Ltd. (PAR) hit the upper circuit on NSE at Rs 114.96 on 28 October 2026.
• The session move was +5% against a previous close of Rs 109.49.
• Market capitalisation stood at Rs 134.72 crore with a PE ratio of 9.3.
• This is the 2nd straight session at the upper circuit, with the run starting on 27 October 2026.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric	Value
Stock	Par Drugs And Chemicals Ltd.
Current Price / LTP	Rs 114.96
Day Move	5%
Previous Close	Rs 109.49
Day Open	Rs 109.49
Day High	Rs 114.96
Day Low	Rs 105.01
Upper Circuit Price	Rs 114.96
Upper Circuit Limit	Rs 114.96
Market Cap	Rs 134.72 crore
Selected Exchange	NSE
PE Ratio	9.3

All figures above are as of 28 October 2026, sourced from Univest market data for the NSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

The stock opened at Rs 109.49 on NSE, level with the previous close, with a day low of Rs 105.01 and the Rs 114.96 band as the high of the session. That is a gain of Rs 5.47, or 5%, measured against the reference price the band is built from.

Because bands, day ranges and previous-close values can differ between exchanges, all figures here come from NSE only. Rs 114.96 was the band limit for the session, and the price touched it.

The Par Drugs And Chemicals Upper Circuit Streak So Far

This is session 2 of an unbroken run for Par Drugs And Chemicals Ltd. The streak began on 27 October 2026, from a base price of Rs 104.28. Across the run the stock has moved 10.24% in total.

A repeated upper circuit matters more than a single one. It says the order book has stayed one-sided across multiple sessions rather than reacting to a single day of news, and for anyone holding the stock it means the price on screen has been hard to trade at for several days running.

This page is the running record for the streak and is updated each session rather than being replaced by a fresh article. That keeps one address for the event instead of splitting the same story across competing pages.

Why Par Drugs And Chemicals Ltd. Hit Upper Circuit

Buying interest took Par Drugs And Chemicals Ltd. up to the limit of its exchange-defined price band. No official company announcement or verified external catalyst was confirmed at the time of writing, so price action and market sentiment are the only available reading.

In the absence of anything verified, this piece does not tie the move to earnings, a corporate action, sector news or market rumours. A confirmed announcement, should one emerge, would be handled in a separate update. The stock reached Rs 114.96 during the session.

What the Par Drugs And Chemicals Upper Circuit Means

An upper circuit is the highest price the exchange band allows in a session, and trading cannot go beyond it. For Par Drugs And Chemicals Ltd., that limit was Rs 114.96 on 28 October 2026.

Bands exist to slow extreme moves and keep trading orderly. Because a band is built from a reference price, the starting point is reset for each session, which is a rule of the mechanism and not a forecast of where the price will go.

Par Drugs And Chemicals Ltd. Fundamentals and Valuation

Reported data adds context that price alone cannot. On a market cap of Rs 134.72 crore, Par Drugs And Chemicals Ltd. showed a PE ratio of 9.3, a PB ratio of 1.15, EPS of 11.78 and a book value of Rs 94.84 per share. These are descriptive figures and not a buy, sell or hold view.

A PB ratio of 1.15 means the market valued the company above its reported book value per share. That premium can reflect growth expectations, asset quality or thin trading in a smaller counter. A sharp one-day move draws attention, yet valuation and return ratios still need a separate review, since the price event and the financial profile answer different questions.

Peer and Sector Context

Par Drugs And Chemicals Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company	Market Cap	PE	PB	ROE
Advanced Enzyme Technologies Ltd.	Rs 2905.78 crore	17.52	1.75	11.43%
Hikal Ltd.	Rs 2494.37 crore	–	2.09	-3.97%
Fredun Pharmaceuticals Ltd.	Rs 2490.64 crore	56.84	8.17	16.09%
Dishman Carbogen Amcis Ltd.	Rs 2314.9 crore	143.25	0.35	1.56%
Beta Drugs Ltd.	Rs 2151.07 crore	41.43	4.91	18.78%

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

Several of these peers are far larger by market capitalisation than Par Drugs And Chemicals Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Par Drugs And Chemicals Ltd.’s PE ratio was 9.3, compared with an available peer PE average of 64.76, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 86.13.

What Readers Should Know

Only a few points are confirmed: Par Drugs And Chemicals Ltd. reached the NSE upper circuit of Rs 114.96 on 28 October 2026 after a 5% day move, and no official catalyst was confirmed at the time of writing.

In practice a band hit is hard to act on. Buyers queue at the limit while sellers step back, so the quoted price may not be one at which an order fills, and a band that is full on one side leaves little to trade against.

Treat sessions like this as market updates and not as conclusions. Business fundamentals, valuation, liquidity, risk and confirmed company disclosures each call for their own check.

Frequently Asked Questions

Why did Par Drugs And Chemicals Ltd. hit upper circuit on 28 October 2026?

The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

How many sessions has Par Drugs And Chemicals Ltd. hit upper circuit in a row?

This is session 2 of the current run, which began on 27 October 2026. This page is updated each session rather than replaced with a new article.

What was PAR share price on 28 October 2026?

The last traded price used in this article was Rs 114.96 on NSE. That price matched the upper circuit price captured for the event.

What was the upper circuit price for PAR?

The upper circuit price was Rs 114.96. The stated exchange upper circuit limit was Rs 114.96. The event numbers in this article are aligned to NSE.

What is Par Drugs And Chemicals Ltd.’s market cap and PE ratio?

Par Drugs And Chemicals Ltd.’s market cap was Rs 134.72 crore. PE ratio was 9.3.

Which exchange and data source were used?

The selected exchange was NSE. The article uses Univest market data available at the time of generation, captured on 28 October 2026.

Does hitting an upper circuit mean Par Drugs And Chemicals Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Par Drugs And Chemicals Ltd. shares when the stock is at the upper circuit?

It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.

What happens the next trading session after an upper circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the upper circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Par Drugs And Chemicals Ltd. the stated limit was Rs 114.96. For this session, Par Drugs And Chemicals Ltd. moved 5%.